Pediatric pulmonary veno-occlusive disease associated with a novel BMPR2 variant

Wataru Takemori1, Kenichiro Yamamura1,2, Yoshitaka Tomita1

  • 1Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Pediatric Pulmonology
|March 1, 2022
PubMed

Insights

Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) share genetic links. A pediatric case with a BMPR2 variant highlights PVOD and I/HPAH as a spectrum of pulmonary vascular disease.

Area of Science:

  • Cardiovascular Sciences
  • Genetics
  • Pediatric Pulmonology

Background:

  • Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) are severe forms of pulmonary hypertension (PH) with distinct genetic underpinnings.
  • A pediatric case of severe PH, initially refractory to treatment and presenting with hypoxemia and ground-glass opacities, was diagnosed as PVOD.

Discussion:

  • The patient developed pulmonary edema following prostaglandin I2 administration, a known complication in PVOD.
  • Pathological examination of the explanted lung revealed characteristic PVOD findings: intimal thickening and luminal narrowing of pulmonary veins.
  • Genetic analysis identified a novel BMPR2 splice acceptor variant (c.77-2A>C), a mutation typically associated with I/HPAH.

Key Insights:

  • This case represents the first pediatric instance of PVOD associated with a BMPR2 variant.
  • The findings challenge the strict classification of PVOD and I/HPAH, suggesting they exist on a continuum of pulmonary vascular disease.
  • The BMPR2 gene, implicated in I/HPAH, may also play a role in the pathogenesis of PVOD.

Outlook:

  • Further research into the genetic landscape of PVOD is warranted to understand the role of BMPR2 and other genes.
  • This case underscores the importance of genetic testing in diagnosing complex pediatric PH cases.
  • Expanding the understanding of the PVOD and I/HPAH spectrum may lead to improved diagnostic strategies and targeted therapies for pediatric PH.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
312
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.2K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
925
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
659
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
258
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K